$5.73
00.00%
Last update: Sep 20, 4:04 PM
15 minutes delayed
Inozyme Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Inozyme Pharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $-0.44 | $-0.39 | -12.8 % |
Mar 2024 | 2024-05-07 | $-0.38 | $-0.36 | -5.56 % |
Dec 2023 | 2024-03-12 | $-0.33 | $-0.32 | -3.12 % |
Sep 2023 | 2023-11-07 | $-0.29 | $-0.32 | 9.38 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Inozyme Pharma (INZY) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 6, 2024 for Q2.
The Actual EPS was $-0.44, which missed the estimate of $-0.39.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.